Stephen Chapman
Chief Executive Officer en NATERA, INC. .
Fortuna: 21 M $ al 31/03/2024
Perfil
En la actualidad, Stephen Chapman ocupa el cargo de Presidente, Director General y Director de Natera, Inc. En su anterior carrera, el Sr. Chapman ocupó el cargo de Director Regional en Genzyme Corp. y Director de la Universidad de California, Los Ángeles. Se licenció en la Universidad de California, Los Ángeles.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
NATERA, INC.
0.19% | 15/04/2024 | 227 710 ( 0.19% ) | 21 M $ | 31/03/2024 |
Cargos activos de Stephen Chapman
| Empresas | Cargo | Inicio |
|---|---|---|
| NATERA, INC. | Chief Executive Officer | 02/01/2019 |
Antiguos cargos conocidos de Stephen Chapman.
| Empresas | Cargo | Fin |
|---|---|---|
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/01/2010 |
| University of California, Los Angeles | Corporate Officer/Principal | - |
Formación de Stephen Chapman.
| University of California, Los Angeles | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| NATERA, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Stephen Chapman
